Gilead Sciences, Inc. (NASDAQ:GILD) stock rose 5.44% (As on August 4, 12:04:46 AM UTC-4, Source: Google Finance) after the company reported lower second-quarter profit as...
The post Gilead… Read More
Philadelphia Trust Co., a reputable institutional investor, recently announced that it has reduced its holdings in Gilead Sciences, Inc. (NASDAQ:GILD) by 5.7% during the first quarter of thi… Read More
Bet_Noire
Acumen Prescription drugs (NASDAQ:ABOS), Institution Labs (NASDAQ:ESTA), Arcus Biosciences (NYSE:RCUS) and BridgeBio Pharma (NASDAQ:BBIO) are 4 of BTIG’s prime picks for sm… Read More
Amgen (NASDAQ:AMGN) has just been upgraded by equities research analysts at StockNews.com from a “buy” rating to a “strong-buy” rating in a report released yesterday… Read More
In the ever-changing world of finance, it can be challenging to stay up-to-date on the latest investment strategies and market trends. One such strategy that has been gaining steam in recent… Read More
According to Benzinga, equity analysts at SVB Leerink raised their price objective for Gilead Sciences (NASDAQ: GILD) in a research note distributed to investors on Tuesday. The new price ob… Read More
Sign up for MarketBeat All Access to gain access to MarketBeat’s full suite of research tools:You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium… Read More
Gilead Sciences, Inc. (NASDAQ:GILD) stock rose 6.41% (As on August 3, 11:43:28 AM UTC-4, Source: Google Finance) after the company said its second-quarter adjusted profit...
The post Gilead… Read More
ViiV Healthcare, majority-owned by GSK Plc GSK, Pfizer Inc PFE, and Shionogi Limited, announced 12-month findings from the SOLAR Phase 3b study… Read More
Investing in the stock market can be a great way to grow your wealth and achieve financial security. However, it is essential to research and understand the best stocks to buy before you jum… Read More
The Standards and Poor’s 500, or S&P 500, is one of the world’s most widely tracked stock market indices. Containing 500 of the largest publically traded US companies by mark… Read More
Gilead Sciences, Inc. (NASDAQ:GILD) stock fell 5.18% (As on Feb 2, 11:42:02 AM UTC-4, Source: Google Finance) after the company posted mixed results for the...
The post Gilead Sciences, Inc… Read More
Gilead Sciences, Inc. (NASDAQ: GILD) stock fell over 1.4% on 29th October, 2020 (As of 11:08 am GMT-4; Source: Google finance) after the company posted...The post Why Gilead Sciences, Inc. (… Read More
Recessions aren’t fun to live through. But if you’re prepared, they don’t have to be painful for your S&P 500 portfolio, either.
X
Eight stocks in the S&P 500, i… Read More
– Quantitative three-pronged program to improve bone and total body health –ASHBURN, Va., Sept. 16, 2022 /PRNewswire/ — Osteoporosis is a complex and multifactorial di… Read More
Approval is based on the Phase 3 KEYNOTE-716 TrialMelanoma is the most serious of all skin cancers, with over 5,000 Canadians diagnosed each year.1,2KIRKLAND, QC, Sept. 13, 2022 /CNW/ &ndash… Read More
Gilead Sciences, Inc.(NASDAQ: GILD) stock lost over 5.3% on October 27th, 2017 (as of 11:20AM EDT; Source: Google finance) hurt by the group’s weak product...
The post Why Gilead… Read More
Gilead Sciences, Inc. (NASDAQ: GILD) stock lost over 4.6% on 25th October, 2019 (as of 12:31 pm GMT-4; Source: Google finance) after the company posted...
The post Healthcare stock under pre… Read More
Gilead Sciences, Inc. (NASDAQ: GILD) stock fell 1.8% on July 26th, 2018 (as of 10:35 AM GMT-4; Source: Google finance) after the company announced that...
The post Pharma stock to watch: Gil… Read More
Oncology stocks cater to the philanthropic investors out there. But caring about our fellow humans can pay some nice income, too.
And just because you are helping a great cause doesn’t… Read More
VANCOUVER, British Columbia–(BUSINESS WIRE)–Pioneer Media Holdings Inc. (“Pioneer” or the “Company”) is pleased to announce it has entered into a non-bin… Read More
There is an old saying about the stock market: ” A bull market will climb a wall of worry, while a bear market will slide a slippery slope of hope.” Loosely translated, that mean… Read More
The Hourly View for Merck
At the moment, MRK’s price is up $0.01 (0.01%) from the hour prior.
Merck has seen its price go down 4 out of the past 5 hours, thus creating some compelling… Read More
Gilead Sciences (Nasdaq: GILD) made a lot of headlines earlier in the year when President Trump received the company’s drug remdesivir as part of his treatment for COVID-19.
Since then… Read More
New York, New York--(Newsfile Corp. - September 14, 2020) - The following statement is being issued by Levi & Korsinsky, LLP:To view an enhanced version of this graphic, please visit:htt… Read More
COVID in the U.S. remains under control, and tracking down, despite an uptick in fatalities perhaps related to delayed reporting from the recent holiday weekend:
COVID Tracking ProjectThe… Read More